Home / Peptides / Selank

Selank Dosage: What the Evidence Says (2026)

Not FDA-approved

Tuftsin-analogue peptide used in Russia. Not FDA-approved and not compoundable in the US.

Also called: TP-7

Regulatory status (US)

Not approved by the FDA for any use. Its nomination for pharmacy compounding was withdrawn, so it is on none of FDA's 503A lists and is not covered by the October 2026 HHS draft policy. In practice that means no legal US source for human use.

What it is

A seven-amino-acid peptide built on tuftsin, an immune peptide.

Dosage

No established human dose. No FDA label or published dose-finding trial gives a dose for Selank. Numbers you see on seller sites or forums are not based on reviewed human studies, so we do not list them.
Selank is not mixed with water and drawn into a syringe, so the reconstitution calculator does not apply.

What human studies show

Safety

Questions

Is Selank FDA-approved?
Not approved by the FDA for any use. Its nomination for pharmacy compounding was withdrawn, so it is on none of FDA's 503A lists and is not covered by the October 2026 HHS draft policy. In practice that means no legal US source for human use.
What dose of Selank has been studied?
There is no established human dose. Clinical studies are almost all Russian-language. There is no FDA-reviewed dosing.

Related

Sermorelin

The first 29 amino acids of GHRH. Former brand Geref was withdrawn in 2009; no product is marketed today.

BPC-157

15-amino-acid peptide studied mostly in animals. Not approved; no established human dose.

TB-500 (thymosin beta-4)

Name used for thymosin beta-4 and for a 7-amino-acid fragment of it. Not approved; no human dose data for the fragment.

GHK-Cu (copper peptide)

Copper-binding tripeptide used in skin care. Topical studies only; no human injection data.

Sources

  1. FDA: 503A bulk drug substance categories (updated May 14, 2026, PDF)

Last checked 2026-11-16. How we pick and check sources: methodology.